| 763758 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis |
2021-11-01 |
10.1136/jitc-2021-002875corr1 |
|
| 763757 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion |
2021-11-01 |
10.1136/jitc-2021-003480 |
D'Alise Anna Morena, Leoni Guido, De Lucia Maria, Langone Francesca, Nocchi Linda, Tucci Fabio Giovanni, Micarelli Elisa, Cotugno Gabriella, Troise Fulvia, Garzia Irene, Vitale Rosa, Bignone Veronica, Di Matteo Elena, Bartolomeo Rosa, Charych Deborah H, Lahm Armin, Zalevsky Jonathan, Nicosia Alfredo, Scarselli Elisa |
| 763756 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies |
2021-11-01 |
10.1136/jitc-2021-002444corr1 |
|
| 763755 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067 |
2021-11-01 |
10.1136/jitc-2021-003743 |
Regan Meredith M, Mantia Charlene M, Werner Lillian, Tarhini Ahmad A, Larkin James, Stephen Hodi F, Wolchok Jedd, Postow Michael A, Stwalley Brian, Moshyk Andriy, Ritchings Corey, Re Sandra, van Dijck Wim, McDermott David F, Atkins Michael B |
| 763754 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study |
2021-11-01 |
10.1136/jitc-2021-003323 |
Sun Ryan, McCaw Zachary, Tian Lu, Uno Hajime, Hong Fangxin, Kim Dae Hyun, Wei Lee-Jen |
| 763753 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells |
2021-11-01 |
10.1136/jitc-2021-003065 |
Nouri Yasmin, Weinkove Robert, Perret Rachel |
| 763752 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma |
2021-11-01 |
10.1136/jitc-2021-003679 |
Singh Kirit, Hotchkiss Kelly M, Mohan Aditya A, Reedy Jessica L, Sampson John H, Khasraw Mustafa |
| 763751 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes |
2021-11-01 |
10.1136/jitc-2021-003214 |
Chen Xiaofeng, Wang Deqiang, Liu Jing, Qiu Jingrong, Zhou Jun, Ying Jieer, Shi Yan, Wang Zhaoxia, Lou Haizhou, Cui Jiuwei, Zhang Jingdong, Liu Yunpeng, Zhao Fengjiao, Pan Lanlan, Zhao Jianyi, Zhu Dongqin, Chen Shiqing, Li Xiangcheng, Li Xue, Zhu Liuqing, Shao Yang, Shu Yongqian |
| 763750 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma |
2021-11-01 |
10.1136/jitc-2021-003261 |
Brendlin Andreas Stefan, Peisen Felix, Almansour Haidara, Afat Saif, Eigentler Thomas, Amaral Teresa, Faby Sebastian, Calvarons Adria Font, Nikolaou Konstantin, Othman Ahmed E |
| 763749 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups |
2021-11-01 |
10.1136/jitc-2021-003683 |
Hsiehchen David, Espinoza Magdalena, Valero Cristina, Ahn Chul, Morris Luc G T |
